Matches in DBpedia 2016-04 for { <http://dbpedia.org/resource/GlySens_ICGM> ?p ?o }
Showing triples 1 to 56 of
56
with 100 triples per page.
- GlySens_ICGM abstract "GlySens, a biomedical technology company, is a privately owned corporation developing a long term internal continuous glucose monitor in order to effectively manage and observe glucose levels in real-time.The GlySens ICGM system is the world's first surgically implanted CGM system to demonstrate an 18-month performance in a preclinical setting. GlySens Incorporated was founded in1998 by David A. Gough and Joseph Lucisano, a UCSD Bioengineering graduate. The ICGM system uses an internal sensor equipped with electro-chemical detectors to measure glucose readings via a chemical reaction between enzymes and oxygen. With an expected release in 2016, the GlySens ICGM will be the first publicly available glucose monitor capable of withstanding 12+ months of continual use. As the global population of diabetics approached 400 million, this device can dramatically improve the quality of diabetic care.".
- GlySens_ICGM foundingYear "1998".
- GlySens_ICGM industry Health_care.
- GlySens_ICGM location San_Diego.
- GlySens_ICGM numberOfEmployees "49".
- GlySens_ICGM revenue "2.5".
- GlySens_ICGM type Privately_held_company.
- GlySens_ICGM wikiPageExternalLink www.glysens.com.
- GlySens_ICGM wikiPageID "48223858".
- GlySens_ICGM wikiPageLength "10482".
- GlySens_ICGM wikiPageOutDegree "13".
- GlySens_ICGM wikiPageRevisionID "697899264".
- GlySens_ICGM wikiPageWikiLink Category:Biotechnology_companies_of_the_United_States.
- GlySens_ICGM wikiPageWikiLink Dexcom.
- GlySens_ICGM wikiPageWikiLink Health_care.
- GlySens_ICGM wikiPageWikiLink Hyperglycemia.
- GlySens_ICGM wikiPageWikiLink Hypoglycemia.
- GlySens_ICGM wikiPageWikiLink JDRF.
- GlySens_ICGM wikiPageWikiLink Medtronic.
- GlySens_ICGM wikiPageWikiLink National_Institutes_of_Health.
- GlySens_ICGM wikiPageWikiLink Privately_held_company.
- GlySens_ICGM wikiPageWikiLink San_Diego.
- GlySens_ICGM wikiPageWikiLink Science_Translational_Medicine.
- GlySens_ICGM wikiPageWikiLink Telemetry.
- GlySens_ICGM wikiPageWikiLink World_Health_Organization.
- GlySens_ICGM wikiPageWikiLinkText "GlySens ICGM".
- GlySens_ICGM founder "Joseph Y. Lucisano & David A. Gough".
- GlySens_ICGM industry "Health Care and Social Assistance".
- GlySens_ICGM location "San Diego, California, U.S.".
- GlySens_ICGM name "GlySens Incorporated".
- GlySens_ICGM numEmployees "49".
- GlySens_ICGM owner "Privately Owned".
- GlySens_ICGM products "ICGM".
- GlySens_ICGM revenue "$2.5 - 5 million".
- GlySens_ICGM type Privately_held_company.
- GlySens_ICGM wikiPageUsesTemplate Template:Advert.
- GlySens_ICGM wikiPageUsesTemplate Template:Infobox_company.
- GlySens_ICGM wikiPageUsesTemplate Template:Reflist.
- GlySens_ICGM wikiPageUsesTemplate Template:Start_date_and_age.
- GlySens_ICGM wikiPageUsesTemplate Template:URL.
- GlySens_ICGM subject Category:Biotechnology_companies_of_the_United_States.
- GlySens_ICGM hypernym World.
- GlySens_ICGM type Agent.
- GlySens_ICGM type Company.
- GlySens_ICGM type Organisation.
- GlySens_ICGM type Organization.
- GlySens_ICGM type Agent.
- GlySens_ICGM type SocialPerson.
- GlySens_ICGM type Thing.
- GlySens_ICGM type Q43229.
- GlySens_ICGM comment "GlySens, a biomedical technology company, is a privately owned corporation developing a long term internal continuous glucose monitor in order to effectively manage and observe glucose levels in real-time.The GlySens ICGM system is the world's first surgically implanted CGM system to demonstrate an 18-month performance in a preclinical setting. GlySens Incorporated was founded in1998 by David A. Gough and Joseph Lucisano, a UCSD Bioengineering graduate.".
- GlySens_ICGM label "GlySens ICGM".
- GlySens_ICGM wasDerivedFrom GlySens_ICGM?oldid=697899264.
- GlySens_ICGM homepage www.glysens.com.
- GlySens_ICGM isPrimaryTopicOf GlySens_ICGM.
- GlySens_ICGM name "GlySens Incorporated".